drugset / Trial / NCT02184364

Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints

NCT02184364

Phase 3 Completed 161 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate, relative to placebo and conjugated oestrogens, the efficacy, safety and tolerability of a 12 weeks peroral treatment twice daily with a cimicifuga racemosa extract corresponding to 20 mg, 75 mg or 150 mg plant material on menopause-related neurovegetative and mental complaints

Timeline

Start
1998-11
Primary completion
2000-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Black Cohosh Traditional medicine (herbal / TCM) 20 mg Oral
Subject Black Cohosh Traditional medicine (herbal / TCM) 75 mg Oral
Subject Black Cohosh Traditional medicine (herbal / TCM) 150 mg Oral
Comparator Oestrofeminal® Unknown

Indications

No indication recorded.